Cargando…

Pilot study on a regional citrate anticoagulated continuous venovenous hemodiafiltration protocol with variable treatment dose

Detalles Bibliográficos
Autores principales:	Slowinski, T, Lieker, I, Khadzhynov, D, Sander, M, Morgera, S, Neumayer, H, Peters, H
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2934547/ http://dx.doi.org/10.1186/cc8750

Ejemplares similares

Recurrent early filter clotting in regional citrate anticoagulated continuous venovenous hemodialysis due to undetected antibodies to heparin-platelet factor 4 complexes
por: Slowinski, T, et al.
Publicado: (2010)

Regional citrate anticoagulation in high-volume continuous venovenous hemodialysis
por: Kalb, R, et al.
Publicado: (2011)

Dynamics of the dosage of citrate-calciuminfusion regimens as anticoagulation in continuous venovenous hemodiafiltration
por: Marin Mateos, H, et al.
Publicado: (2015)

Blood epuration of middle molecules in continuous venovenous hemodiafiltration with regional citrate anticoagulation versus systemic heparinization
por: Nogier, MB, et al.
Publicado: (2009)

Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study
por: Slowinski, Torsten, et al.
Publicado: (2015)

Regional citrate anticoagulation (RCA) for continuous venovenous hemodiafiltration (CVVHDF): initial experience
por: Durão, M, et al.
Publicado: (2001)

Flexitrate regional citrate anticoagulation in continuous venovenous hemodiafiltration: a retrospective analysis
por: Lenga, Ilan, et al.
Publicado: (2019)

Hypercitratemia is a mortality predictor among patients on continuous venovenous hemodiafiltration and regional citrate anticoagulation
por: dos Santos, Thais Oliveira Claizoni, et al.
Publicado: (2023)

Regional Anticoagulation with Citrate is Superior to Systemic Anticoagulation with Heparin in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration
por: Park, Joon-Sung, et al.
Publicado: (2011)

Citrate anticoagulation realized as CVVHD using a newly designed dialysate solution
por: Morgera, S, et al.
Publicado: (2006)

Multicenter prospective observational study on safety and efficacy of regional citrate anticoagulation in CVVHD in the presence of liver failure: the Liver Citrate Anticoagulation Threshold Study (L-CAT)
por: Slowinski, T, et al.
Publicado: (2011)

Role of early continuous venovenous hemodiafiltration in septic shock and multiorgan failure
por: Soliman, M, et al.
Publicado: (2010)

Pharmacokinetics and pharmacodynamics of esomeprazole and ranitidine during continuous venovenous hemodiafiltration
por: Fuhrmann, V, et al.
Publicado: (2013)

Pharmacokinetics of daptomycin in patients undergoing low-flow continuous venovenous hemodiafiltration
por: Ide, TI, et al.
Publicado: (2015)

Variability in Uremic Control during Continuous Venovenous Hemodiafiltration in Trauma Patients
por: Beitland, Sigrid, et al.
Publicado: (2012)

Validation of a Protocol for Continuous Hemodiafiltration with Regional Citrate Anticoagulation with Omni®
por: Whiting, Livia, et al.
Publicado: (2022)

Continuous venovenous hemodiafiltration with a low citrate dose regional anticoagulation protocol and a phosphate-containing solution: effects on acid–base status and phosphate supplementation needs
por: Morabito, Santo, et al.
Publicado: (2013)

Effectiveness of continuous venovenous hemodiafiltration using a polymethylmethacrylate membrane hemofilter in septic shock patients
por: Sakamoto, Y, et al.
Publicado: (2008)

Impact of continuous veno-venous hemodiafiltration with regional citrate anticoagulation on the acid-base balance of critically ill patients
por: Passos, RH, et al.
Publicado: (2006)

Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients
por: Aguilar, Gerardo, et al.
Publicado: (2017)

Amino acid concentrations in serum, urine and dialysate/ultrafiltrate solutions of continuous venovenous hemodiafiltration patients
por: Lee, JM, et al.
Publicado: (2012)

Impedance cardiography in the estimation of hemodynamic and fluid status of coma patients during continuous venovenous hemodiafiltration
por: De Nicola, A, et al.
Publicado: (2009)

Acid base variables predict survival early in the course of treatment with continuous venovenous hemodiafiltration
por: Passos, Rogério da Hora, et al.
Publicado: (2018)

Citrate anticoagulation for continuous venovenous haemodiafiltration: the impact of a novel protocol on patients receiving therapy in one regional hospital
por: Highgate, J, et al.
Publicado: (2015)

Cefiderocol Pharmacokinetics in a Patient Receiving Continuous Venovenous Hemodiafiltration
por: Kobic, Emir, et al.
Publicado: (2021)

Intermittent versus continuous enoxaparine for anticoagulation during continuous venovenous hemofiltration
por: Koroljov, A, et al.
Publicado: (2008)

Near-infrared spectroscopy parameters in patients undergoing continuous venovenous hemodiafiltration
por: Chaves, Renato Carneiro de Freitas, et al.
Publicado: (2019)

Effect of Phoxilium on prognostic predictors in patients undergoing continuous venovenous hemodiafiltration
por: Kim, Da Woon, et al.
Publicado: (2021)

Characteristics of continuous venovenous hemodiafiltration in the acute treatment of inherited metabolic disorders
por: Eminoğlu, Fatma Tuba, et al.
Publicado: (2021)

Carbon dioxide elimination during continuous venovenous hemodiafiltration (CVVHD)-laboratory experiment
por: Ruzicka, J, et al.
Publicado: (2000)

Comparison of the efficacy and safety of two regional citrate anticoagulation protocols using acid citrate dextrose A or Prismocitrate 10/2, in patients with acute renal failure undergoing continuous venovenous haemodiafiltration
por: Ooi, EL, et al.
Publicado: (2010)

Comparison of Sustained Hemodiafiltration with Acetate-Free Dialysate and Continuous Venovenous Hemodiafiltration for the Treatment of Critically Ill Patients with Acute Kidney Injury
por: Abe, Masanori, et al.
Publicado: (2011)

A Retrospective Review of the Use of Regional Citrate Anticoagulation in Continuous Venovenous Hemofiltration for Critically Ill Patients
por: Leung, Anne Kit-Hung, et al.
Publicado: (2013)

Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study
por: Schultheiß, Caroline, et al.
Publicado: (2012)

Effectiveness of continuous venovenous hemodiafiltration using a polymethylmethacrylate membrane hemofilter judging from a multiplex suspension array system in septic shock patients
por: Sakamoto, Y, et al.
Publicado: (2011)

Atenolol and amlodipine combination overdose managed with continuous venovenous hemodiafiltration: A case report
por: Sandeep, P., et al.
Publicado: (2014)

Evaluation of optimized continuous venovenous hemodiafiltration therapy efficiency in severe burn patients with sepsis
por: Xu, Cheng, et al.
Publicado: (2014)

Optimizing ceftolozane-tazobactam dosage in critically ill patients during continuous venovenous hemodiafiltration
por: Aguilar, Gerardo, et al.
Publicado: (2019)

Continuous hemodiafiltration for hypercytokinemia in tumor lysis syndrome
por: Nakamura, M, et al.
Publicado: (2005)

Continuous venovenous hemodiafiltration in the treatment of newborns with an inborn metabolic disease: a single center experience
por: AKDUMAN, Hasan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s7cdn3k51fgvgvrfetmudbh32t